Youdim Pharmaceuticals

About

Portfolio · 5

ENDOPUMP

The new generation of therapy for Parkinson

1 round Latest: 2019-01

Touch Brain

Parkinson's Disease Treatment

1 round Latest: 2017-11

NeurOptic

Therapy for Glaucoma

1 round Latest: 2017-11

Curewize Health

Personalized Cancer Treatment

2 rounds $1.0M committed Latest: 2016-09

BioShai

Blood Test for Early Detection of Parkinsons Disease

1 round Latest: 2014-01

Investment activity

Q&A

What is Youdim Pharmaceuticals' primary investment focus?

Youdim Pharmaceuticals specializes in the development of therapeutic and diagnostic solutions, primarily in the areas of neurological disorders and cancer. Their portfolio companies, such as BioShai and ENDOPUMP, reflect this focus.

Which investment stages does Youdim Pharmaceuticals typically target?

Youdim Pharmaceuticals typically invests in Pre-Seed, A Round, and Seed stages.

Can you name some of Youdim Pharmaceuticals' portfolio companies?

Youdim Pharmaceuticals' portfolio includes companies like Curewize Health, which focuses on personalized cancer treatment.

When was Youdim Pharmaceuticals founded?

Youdim Pharmaceuticals was founded in 1997.

Who leads Youdim Pharmaceuticals?

Youdim Pharmaceuticals is led by Professor Moussa Youdim, who serves as President & CSO.

What is Youdim Pharmaceuticals' geographic focus for investments?

Youdim Pharmaceuticals is based in Yokne'am Illit, Israel, and focuses its investments within Israel.

Has Youdim Pharmaceuticals made any recent investments?

Yes, Youdim Pharmaceuticals invested in ResQ Medical, a company founded in 2022, which raised $800K in a Seed round.

What is the sector concentration of Youdim Pharmaceuticals' portfolio?

All of Youdim Pharmaceuticals' portfolio companies are concentrated in the Health Tech & Life Sciences sector.